tm logo
MYOVANT
Live/Registered
REGISTERED

on 02 Oct 2018

Last Applicant/ Owned by

CH-4051 Basel

CH

Serial Number

79230988 filed on 09th Feb 2018

Registration Number

5572795 registered on 02th Oct 2018

in the Principal Register

Correspondent Address

Joyce M. Ferraro

Fross Zelnick Lehrman & Zissu, P.C.

4 Times Square, 17th Floor

New York NY 10036

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

MYOVANT

Information services in the field of health and medicine and provision of information regarding medicines and drugs for medical use via a website Pharmaceutical and biological preparations for medical use for the treatment of gynecological disorders, endocrine-related disorders, uterine fibroids, endometriosis, infertility, cancer, and prostate cancer

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Information services in the field of health and medicine and provision of information regarding medicines and drugs for medical use via a website

Class [005]
Pharmaceutical Products


Pharmaceutical and biological preparations for medical use for the treatment of gynecological disorders, endocrine-related disorders, uterine fibroids, endometriosis, infertility, cancer, and prostate cancer

Mark Details


Serial Number

No 79230988

Mark Type

No Service Mark

Attorney Docket Number

No MYOV 1801453

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th Oct 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02th Feb 2019FINAL DECISION TRANSACTION PROCESSED BY IB
15th Jan 2019FINAL DISPOSITION PROCESSED
15th Jan 2019FINAL DISPOSITION NOTICE SENT TO IB
02th Jan 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02th Oct 2018REGISTERED-PRINCIPAL REGISTER
17th Jul 2018PUBLISHED FOR OPPOSITION
17th Jul 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27th Jun 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23rd Jun 2018REFUSAL PROCESSED BY IB